IL24813A - Sustained release compositions - Google Patents

Sustained release compositions

Info

Publication number
IL24813A
IL24813A IL24813A IL2481365A IL24813A IL 24813 A IL24813 A IL 24813A IL 24813 A IL24813 A IL 24813A IL 2481365 A IL2481365 A IL 2481365A IL 24813 A IL24813 A IL 24813A
Authority
IL
Israel
Prior art keywords
sustained release
release compositions
compositions
sustained
release
Prior art date
Application number
IL24813A
Other languages
English (en)
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of IL24813A publication Critical patent/IL24813A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL24813A 1965-01-26 1965-12-16 Sustained release compositions IL24813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US428210A US3400197A (en) 1965-01-26 1965-01-26 Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules

Publications (1)

Publication Number Publication Date
IL24813A true IL24813A (en) 1969-06-25

Family

ID=23697978

Family Applications (1)

Application Number Title Priority Date Filing Date
IL24813A IL24813A (en) 1965-01-26 1965-12-16 Sustained release compositions

Country Status (11)

Country Link
US (1) US3400197A (US06818201-20041116-C00086.png)
AT (1) AT267068B (US06818201-20041116-C00086.png)
BE (1) BE675379A (US06818201-20041116-C00086.png)
BR (1) BR6576133D0 (US06818201-20041116-C00086.png)
DK (1) DK115350B (US06818201-20041116-C00086.png)
ES (1) ES321779A1 (US06818201-20041116-C00086.png)
FR (2) FR5137M (US06818201-20041116-C00086.png)
GB (1) GB1113860A (US06818201-20041116-C00086.png)
IL (1) IL24813A (US06818201-20041116-C00086.png)
NL (1) NL6516147A (US06818201-20041116-C00086.png)
NO (1) NO119439B (US06818201-20041116-C00086.png)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
JPS56500138A (US06818201-20041116-C00086.png) * 1979-03-16 1981-02-12
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4521402A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of hydrazine
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
AU581177B2 (en) * 1983-05-31 1989-02-16 Choong-Gook Jang Dry direct compression compositions for controlled release dosage forms
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung
GB8518927D0 (en) * 1985-07-26 1985-09-04 Vincent Processes Ltd Tablets
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
ATE321529T1 (de) * 1996-09-30 2006-04-15 Alza Corp Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP1202745A4 (en) * 1999-08-16 2004-09-22 Henceforth Hibernia Inc THERAPEUTIC AND PROPHYLACTIC COMPOSITIONS CONTAINING CATALYTIC BIOMIMETIC SOLIDS AND METHODS OF PREPARING AND USING SAME
US6264983B1 (en) 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
EP1414458B1 (en) * 2001-07-06 2007-04-11 Endo Pharmaceuticals Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
JP2006517929A (ja) * 2003-02-19 2006-08-03 ハー・ルンドベック・アクチエゼルスカベット 溶融アグロメレーションを用いてアグロメレートを製造する方法
WO2004073689A1 (en) * 2003-02-19 2004-09-02 Lifecycle Pharma A/S Use of a silica or silica derivative as a sorption material
US9308164B2 (en) 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
JP3955868B2 (ja) * 2004-12-27 2007-08-08 株式会社キングジム 書類等の綴じ具
BRPI0519481A2 (pt) 2004-12-27 2009-02-03 Beiersdorf Ag glicopirrolato em preparaÇÕes cosmÉticas
DE102005029386A1 (de) * 2005-06-23 2007-01-11 Beiersdorf Ag Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren Hydrokolloiden
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
DE102006046358B3 (de) * 2006-09-28 2007-11-29 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. Verfahren zur Herstellung von funktionellen cellulosischen Formkörpern
AP2986A (en) 2007-02-23 2014-09-30 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics
WO2009135179A2 (en) * 2008-05-02 2009-11-05 Gilead Sciences, Inc. The use of solid carrier particles to improve the processability of a pharmaceutical agent
ME02874B (me) 2010-12-22 2018-04-20 Purdue Pharma Lp Obloženi dozni oblici sa kontrolisanim oslobađanjem otporni na zloupotrebu
CN103327969A (zh) 2010-12-23 2013-09-25 普渡制药公司 抗篡改固体口服剂型
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2951791A (en) * 1959-08-31 1960-09-06 American Cyanamid Co Use of calcium silicate in tablet compressing
US2951792A (en) * 1959-11-18 1960-09-06 Smith Kline French Lab Sustained release pharmaceutical tablets
NL135732A (US06818201-20041116-C00086.png) * 1960-11-17
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical

Also Published As

Publication number Publication date
FR5137M (US06818201-20041116-C00086.png) 1967-06-05
NO119439B (US06818201-20041116-C00086.png) 1970-05-19
AT267068B (de) 1968-12-10
BR6576133D0 (pt) 1973-09-06
FR1465919A (fr) 1967-01-13
BE675379A (US06818201-20041116-C00086.png) 1966-05-31
GB1113860A (en) 1968-05-15
ES321779A1 (es) 1966-06-16
US3400197A (en) 1968-09-03
NL6516147A (US06818201-20041116-C00086.png) 1966-07-27
DK115350B (da) 1969-09-29

Similar Documents

Publication Publication Date Title
IL24813A (en) Sustained release compositions
ZA702585B (en) Hydrocurable compositions
MY6900126A (en) Explosive compositions
MY6900335A (en) Tetrahydro - isoquinolines
IL26254A (en) Pesticidal compositions
MY6900365A (en) Wood-treatment compositions
IL25984A (en) Explosive compositions
CY700A (en) Bronchodilator-expectorant compositions
GB1184741A (en) Binder Composition
IE29337L (en) Detergent-softener composition
IE29423L (en) 3 - iodo - 4 - hydroxy- 5 - nitrobenzonitrile derivatives;¹anthelmintic compositions
IE29343L (en) Anthelmintic compositions
CA704299A (en) Hydroxyalkylformal compositions
AU401666B2 (en) 4-METHYL-PENTENT-l-POLYMER COMPOSITIONS
AU404383B2 (en) Antelmintic compositions
AU406425B2 (en) Antiococcidial compositions
AU410907B2 (en) Insectiphobic compositions
CA721698A (en) Weedicidal compositions
CA719693A (en) Hydrochlorothiazide-alkaloid compositions
CA711331A (en) Polyepoxide-polyamine compositions
IE29342L (en) Herbicidal compositions
MY6800085A (en) Novel vitamin-containing compositions
CA27431S (en) Bouteille
IE30557L (en) Fertiliser-herbicide compositions
IE30266L (en) Polymer-cement compositions